Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 1

Status

Completed 22Unknown 13Recruiting 6Terminated 3Withdrawn 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 2INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gastrointestinal 9Breast 6Gynecologic 3Thoracic 2Other hematologic neoplasm 2Head & Neck 2Tumor-Agnostic 1NET 1Lymphoid 1Endocrine 1Dermatologic 1Classical hematology 1

Conditions

Breast Neoplasms 6Motor Activity 2Sleep Initiation and Maintenance Disorders 1Pain, Postoperative 1Chronic Pain 1

Interventions

pembrolizumab 78Fulvestrant 76Carboplatin 74Trastuzumab 71Capecitabine 70Letrozole 63Cyclophosphamide 61Paclitaxel 60Specimen Handling 54pertuzumab 52Docetaxel 50abemaciclib 46ribociclib 45Anastrozole 36Magnetic Resonance Spectroscopy 35130-nm albumin-bound paclitaxel 35trastuzumab deruxtecan 34Blood Specimen Collection 33exemestane 32Tamoxifen 32Biopsy 32sacituzumab govitecan 31Gemcitabine 30Epirubicin 29pyrotinib 28palbociclib 28Drug Therapy 28Surveys and Questionnaires 27Injections 27eribulin 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Control Groups × Breast × Clear all
NCT04816006 2026-05-20

BRAIN

Mayo Clinic

Phase NA Recruiting
160 enrolled
Breast

Breast Neoplasms, Motor Activity

NCT06039644 2026-03-06

To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer

GenMont Biotech Incorporation

Phase NA Recruiting
100 enrolled
Breast

Breast Neoplasms

NCT05494502 2025-07-31

Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients

Peking University First Hospital

Phase NA Recruiting
1,206 enrolled
Breast

Breast Neoplasms, Pain, Postoperative, Chronic Pain

NCT05297773 2025-02-26

NEO-Program

Fundacao Champalimaud

Phase NA Recruiting
132 enrolled
Breast

Breast Neoplasms, Sleep Initiation and Maintenance Disorders, Motor Activity

NCT05063136 2024-11-04

Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer

Henan Cancer Hospital

Phase 3 Recruiting
1,979 enrolled
Breast

Breast Neoplasms

NCT06605521 2024-09-20

To Evaluate the Efficacy and Safety of Ipsilateral Supraclavicular Lymph Node Dissection for Breast Cancer Patients

Henan Cancer Hospital

Recruiting
300 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡